Entries |
Document | Title | Date |
20080206378 | Anthelmintic Composition - A topical formulation comprising as active ingredients, at least one effective agent derived from | 08-28-2008 |
20080206379 | Production and Use of an Antioxidant Extract from Crypthecodinium Sp. - The invention relates to an antioxidant extract from | 08-28-2008 |
20080206380 | Preventing Agent Against Drug-Resistant Bacterial Infection - The present invention is to provide an agent for preventing and treating drug-resistant bacterial infection for livestock/fowls or fish and shellfish, using particular microbial agents as active components, without using synthetic antibacterial substances or antibiotics, and a method for preventing and treating its infection. By using lactic acid bacteria, their dead bacteria or treated substances thereof, or | 08-28-2008 |
20080260881 | Blue-green algae composition - A broad spectrum functional food formulation based on blue-green algae and concentrated extracts of blue-green algae provides numerous health benefits when orally administered in therapeutically effective amounts. Whole aphanizomenon flos-aqua is combined with concentrates of phycocyanin and phenylethylamine to provide a life-enhancing dietary supplement which can stimulate stem cell production, elevate mood and reduce inflammation and joint pain. | 10-23-2008 |
20080311234 | Oil-in-Water Emulsified Composition, and External Preparation for Skin and Cosmetics Using the Composition - An oil-in-water emulsified composition suitable for external preparation for skin and cosmetic product, which comprised 0.1 to 5% by mass of (A) lipopeptide compound derived from a microorganism such as surfactin and its analogous compound, 0.05 to 1.5% by mass of (B) xanthan gum, 25 to 70% by mass of (C) oil component and (D) water, free from non-ionic surfactants and acrylic water-soluble polymers, and is excellent in feeling upon use, moisture retention, emollient property and stability as well as environmental suitability and safety for living organisms, and external preparation for skin and cosmetic product using the composition. | 12-18-2008 |
20090004312 | Use of Neurotoxin Therapy for Treatment of Urologic and Related Disorders - The present invention related to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin. | 01-01-2009 |
20090017147 | Cosmetic or Dermopharmaceutical Composition Comprising an Euglena Extract - The invention provides a cosmetic or dermopharmaceutic composition containing an | 01-15-2009 |
20090028972 | Treating Neoplasms With Neurotoxin - The present invention provides a method of treating a cancer using a neurotoxin, preferably Botulinum toxin (“BTX”). The application of a neurotoxin around a cancer acts to decrease the contractile forces of the muscles surrounding a neoplasm which normally squeeze cancer cells through efferent channels leaving the cancer vicinity to distant sites. Also, the application of the toxin at sites distant from the cancer enhances cellular and humoral immunologic functions which further contributes to cancer cell death and spread. Following administration of botulinum toxin around and distant to a cancer, it is noticed that local, regional, and distant spread is reduced or eliminated. Immunomodulation with botulinum toxin is also valuable in treating other disease that may or may not be associated with cancers, such as viral-induced growths, viral conditions, fungal disease, chronic wounds, graft versus host disease, autoimmune disease, and HIV. | 01-29-2009 |
20090028973 | Use Of Nocardia Rubra Cell Wall Skeleton In The Preparation Of Anti-HPV Infection Medicaments - The invention refers to use of | 01-29-2009 |
20090028974 | Use of Botulinum Toxin Therapy for Treatment of Recalcitrant Voiding Dysfunction - The present invention related to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin. | 01-29-2009 |
20090053342 | PREPARATION OF MICROBIAL OIL - The present invention provides a process for the production of a microbial oil comprising culturing a micro-organism in a two stage fermentation process where, in a last stage that precedes the end of fermentation, the carbon source is: consumed by the micro-organisms at a rate greater than it is added to the medium; added at a rate #0.30 M carbon/kg medium; or is rate limiting on the growth of the micro-organism. The micro-organisms thus have the carbon source restricted so that they preferentially metabolise fats or lipids other than arachidonic acid (ARA), so increasing the proportion of ARA in the cells. A microbial oil is then recovered from the micro-organism, using hexane as a solvent, that has at least 50% ARA and at least 90% triglycerides. | 02-26-2009 |
20090117216 | Composition and use of phyto-percolate for treatment of disease - This invention relates generally to a method of preparation of a phyto-percolate that is derived from fresh water mixture including algae. The phyto-percolate is believed to contain an enzyme having proteolytic activity. The invention further relates to the use of the phyto-percolate in a variety of disease states. | 05-07-2009 |
20090136604 | BACTERIAL EXTRACTS CULTURED IN THERMAL WATERS FOR TREATING SENSITIVE SKIN, MUCOUS MEMBRANES AND SCALPS - Sensitive skin, mucous membranes and scalps are treated by administering to individuals in need of such treatment, thus effective amounts of at least one extract of a non-photosynthetic and non-fruiting filamentous bacterium cultured in a medium which includes at least one non-sulfurous mineral and/or thermal water, e.g., an extract derived from the bacterium | 05-28-2009 |
20090142429 | SILICIBACTER SP. STRAIN USEFUL FOR GENETIC TRANSFORMATION OF MARINE ALGAE AND PRODUCTION OF ANTIBIOTIC AGENTS | 06-04-2009 |
20090142430 | Methods for Preventing or Treating Complications of Airway Control Devices - Disclosed in certain embodiments is a method of treating or preventing complications of airway control devices comprising administering to a patient having an airway control device a pharmaceutical composition comprising botulinum neurotoxin to one or more of the upper or lower aerodigestive secretory glands, the cricopharyngeus or the gastric or esophageal mucosal wall of the patient. | 06-04-2009 |
20090142431 | ALGAL AND ALGAL EXTRACT DIETARY SUPPLEMENT COMPOSITION - A human dietary supplement composition comprising the dried biomass of bluegreen algae ( | 06-04-2009 |
20090175974 | NOVEL CADHERIN RECEPTOR PEPTIDE FOR POTENTIATING Bt BIOPESTICIDES - Disclosed is a novel cadherin peptide that enhances the toxicity of Cry proteins. A novel insecticide composition comprising an effective amount of cadherin peptide having SEQ. ID. NO:2 and an effective amount of | 07-09-2009 |
20090181116 | AXMI-031, AXMI-039, AXMI-040 AND AXMI-049, A FAMILY OF NOVEL DELTA-ENDOTOXIN GENES AND METHODS FOR THEIR USE - Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for a delta-endotoxin polypeptide are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated delta-endotoxin nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed, and antibodies specifically binding to those amino acid sequences. In particular, the present invention provides for isolated nucleic acid molecules comprising nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO:2, 4, 6, 8, 10, 12, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, or 38, or the nucleotide sequence set forth in SEQ ID NO:1, 3, 5, 7, 9, 11, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, or 37, as well as variants and fragments thereof. | 07-16-2009 |
20090186111 | Novel Bacteria and Pharmaceutically Active Products Obtained Therefrom - A substance obtainable from | 07-23-2009 |
20090196945 | COMPOSITIONS AND METHODS FOR TREATING BACTERIA - The present invention relates to the field of bacteriology. In particular, the present invention provides compositions (e.g., comprising a lantibiotic and mupirocin or gentamicin) and methods of treating (e.g., killing or inhibiting growth of) bacteria. For example, the present invention provides pharmaceutical compounds (e.g., comprising a lantibiotic and mupirocin or gentamicin) and methods of using the same in research, therapeutic and drug screening applications. | 08-06-2009 |
20090214685 | SUSTAINED RELEASE POLOXAMER CONTAINING PHARMACEUTICAL COMPOSITIONS - A thermo-reversible thermoplastic pharmaceutical composition, comprising a botulinum toxin and a biocompatible poloxamer which provides thermoreversibility to the composition and additionally stabilizes the botulinum toxin, is described. The pharmaceutical composition can be administered to a patient as a liquid, and gels after administration into a sustained release drug delivery system from which the biologically active botulinum toxin is released over a multi-day period thereby localizing the drug as a depot and controlling release to enhance the therapeutic effect per dose. | 08-27-2009 |
20090238907 | Topical Compositions Containing Bacillus Coagulans Extracellular Products and Uses Thereof - The present invention discloses compositions derived from an isolated | 09-24-2009 |
20090246303 | Method for Reducing The Effects of Chemotherapy Using Flagellin Related Polypeptides - The use of flagellin and flagellin related polypeptides for reducing cancer treatment side effects in mammals is described. | 10-01-2009 |
20090297647 | Assays, method and compositions that exploit a mycobacterial iron acquistion pathway in cells - Assays for the identification of antibacterial agents that inhibit mycobacterial growth by interfering with the iron acquisition pathway in host cells are disclosed. Also disclosed are methods of inhibiting mycobacterial growth by interfering with iron uptake or by delivering antibacterial agents to mycobacteria in host cells through the iron uptake pathway, as well as certain compounds that are useful in the assay methods, and also as antibacterial agents. | 12-03-2009 |
20100015263 | CONTROLLED RELEASE AURIS SENSORY CELL MODULATOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS - Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with auris sensory cell modulating agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s). | 01-21-2010 |
20100021576 | Bacillus Amyloliquefaciens K317 for Suppressing the Growth of Antibiotics-Resistant Pathogenic Microorganism or Enteropathogenic Microorganism - The present invention relates to a | 01-28-2010 |
20100034908 | Porphyromonas gingivalis polypeptides and nucleotides - The present invention relates to isolated | 02-11-2010 |
20100034909 | Pharmaceutical composition for treating rotavirus and/or respiratory syncytial virus infection and method for preparing the same - The present invention provides a pharmaceutical composition for treating rotavirus and/or respiratory syncytial virus infection and a method for preparing the same; wherein said pharmaceutical composition comprises a therapeutically effective amount of | 02-11-2010 |
20100047374 | COMPOSITION FOR PROTECTING MUSCLE DAMAGE - The present invention aims to provide a composition for protecting a muscle damage having high safety and a stronger muscle damage-protecting effect. The present invention provides a composition for protecting a muscle damage comprising, as an active ingredient, an extract with a lipid-soluble organic solvent of an acetic acid bacterium or preferably an extract with ethyl acetate of an acetic acid bacterium, alkali-stable lipid of an acetic acid bacterium, N-acylsphinganine, sphinganine, amino lipids, or terpenoid compounds. Further, the present invention provides a composition for protecting a muscle damage comprising, as an active ingredient, an extract with a lipid-soluble organic solvent of a vinegar or preferably an extract with ethyl acetate of a vinegar. | 02-25-2010 |
20100151066 | COMPOSITION FOR SUPPRESSING APPETITE, IMPROVING TONE AND MOOD, WITH A NATURAL ANTIDEPRESSANT ACTIVITY AND WITH AN ANTIASTHENIC EFFECT - Compositions comprising L-tryptophan, 5-hydroxytryptophan and/or D-Limonene are used for preparing a product suitable for sublingual or nasal administration which is helpful in suppressing appetite in such a manner as to promote weight loss in an individual; such compositions furthermore exhibit an antidepressant activity and an antiasthenic effect which makes them helpful in improving tone and mood and the level of attention in an individual. The compositions preferably comprise phenylethylamine in a synergistic combination which substance is contained in an algal plant extract, preferably of Klamath algae. | 06-17-2010 |
20100159046 | MINIMAL TISSUE ATTACHMENT IMPLANTABLE MATERIALS - A method for minimizing tissue adhesion at an injured site is provided, the method comprising applying a biocellulose material to the injured site, whereby the adhesion of the tissues at the injured site is minimized, wherein the biocellulose material is at least partially dehydrated. Another embodiment provides an implantable material, which effectively prevents cell adhesion and has desirable mechanical properties. | 06-24-2010 |
20100178371 | COMPOSITION FOR SUPRESSING APPETITE, IMPROVING TONE AND MOOD, WITH A NATURAL ANTIDEPRESSANT ACTIVITY AND WITH AN ANTIASTHENIC EFFECT - Compositions comprising L-tryptophan and/or 5-hydroxytryptophan are used for preparing a product suitable for sublingual or nasal administration which is helpful in suppressing appetite in such a manner as to promote weight loss in an individual; such compositions furthermore exhibit an antidepressant activity and an antiasthenic effect which makes them helpful in improving tone and mood and the level of attention in an individual. The compositions preferably comprise phenylethylamine in a synergistic combination which substance is contained in an algal plant extract, preferably of Klamath algae. | 07-15-2010 |
20100196524 | NOVEL PEPTIDES AND METHODS FOR PRODUCING THEM - The present invention relates to the fields of life sciences and food, feed or pharmaceutical industry. Specifically, the invention relates to novel peptides, pilus structures, polynucleotides as well as vectors, host cells, products and pharmaceutical compositions comprising the polynucleotides, peptides or pilus structures. The invention also relates to gene clusters and antibodies. Furthermore, the present invention relates to methods for producing the peptides or pilus structures or producing the products comprising the peptides or pilus structures. Furthermore, the present invention relates to treatments as well as uses and methods for screening bacterial strains, for reducing or inhibiting the adhesion of pathogenic bacteria, promoting the adhesion of bacterial cells to the mucus and for modifying immune response in a subject. Still, the present invention relates to methods for detecting probiotic bacterial strains or pathogen strains. | 08-05-2010 |
20100203180 | Antimicrobial protein derived from podoviriedae bacteriophage specific to staphylococcus aureus - The present invention relates to a novel antimicrobial protein derived from bacteriophage having killing activity specific to | 08-12-2010 |
20100227013 | BACTERIAL EXTRACT FOR RESPIRATORY DISORDERS AND PROCESS FOR ITS PREPARATION - The present invention relates to an extract from bacterial strains, such as | 09-09-2010 |
20100266717 | CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS - Compositions and methods for controlling molluscs, members of the Gastropoda and Bivalvia classes which includes but is not limited to lactones, lactams, carbamates, amides, and/or carboxylic acid containing compounds as active ingredients and/or compounds derived from | 10-21-2010 |
20100272839 | TREATMENT OF FATTY SCALP WITH A LYSATE OF BIFIDOBACTERIUM SPECIES - The present invention treats a fatty dandruff state of the scalp with a lysate of at least one microorganism of the genus | 10-28-2010 |
20100291251 | METHOD FOR PRODUCTION OF CAROTENOID - The present invention provides a composition comprising a high content of highly pure, low-cost, and safe carotenoid and a method for industrially producing the same. The present invention also provides functional food, a pharmaceutical composition and a cosmetic product comprising such a composition. The present invention further provides a method for producing a composition containing at least 80% of carotenoid, which is characterized in treating a microorganism culture with extraction using a lower alcohol at 80° C. at the lowest or a combination of water and a lower alcohol at 80° C. at the lowest, and then washing and filtrating the precipitate obtained from the extract solution with a combination of a lower alcohol and water. | 11-18-2010 |
20110033567 | Preparation Comprising Mycobacterium Bovis BCG Killed by Extended Freeze Drying (EFD) for Preventing or Treating Rheumatoid Arthritis - Preparation comprising | 02-10-2011 |
20110064835 | PROCESS FOR THE PREPARATION OF ACTIVE PRINCIPLES ON THERMAL WATER AND COMPOSITIONS COMPRISING THEM - The invention relates to a process for the preparation of a cosmetic or dermatological active principle, comprising the culturing of at least one nonphoto-synthetic and nonfruiting filamentous bacterium on a medium comprising at least one nonsulphurous mineral and/or thermal water. It also relates to a cosmetic or dermatological composition comprising at least one bacterium of the genus | 03-17-2011 |
20110159130 | REDUCTION OF ENDOTOXIN IN POLYSIALIC ACIDS - The present invention relates to process for reducing the endotoxin content of a sample of fermentation broth containing polysialic acid and endotoxin comprising the sequential steps: (i) adding to the sample a base having a pKa of at least 12 to form a basic solution having a pH of at least 12, incubating the solution for a pre-determined time at a pre-determined temperature; and (ii) recovery of PSA, suitably by (iii) passing the sample through an anion-exchange column whereby polysialic acid is absorbed on the ion exchange resin; (iv) washing the column with one washing buffer, whereby polysialic acid remains absorbed on the ion exchange resin; and (v) eluting the polysialic acid from the column using an elution buffer to provide a product solution of polysialic acid having reduced endotoxin content. | 06-30-2011 |
20110159131 | USE OF STRAINS OF LACTOBACILLUS AND BY-PRODUCTS THEREOF FOR INHIBITING FORMATION OF BLOOD VESSELS - A lactic composition containing at least a bacterial strain selected from the group consisting of | 06-30-2011 |
20110171334 | ANTIBACTERIAL SUBSTANCE DM0507 AND UTILIZATION OF THE SAME - An object is to provide a more potent novel antimicrobial active substance, which is derived from a naturally occurring substance and has a broad antimicrobial spectrum, and an antimicrobial active substance DM0507 obtained by a production process comprising the following steps (a) to (d):
| 07-14-2011 |
20110177185 | PHARMACEUTICALLY COMPATIBLE METHOD FOR PURIFYING INTACT BACTERIAL MINICELLS - The present invention provides a method for purifying bacterial minicells that involves subjecting a sample containing minicells to density gradient centrifugation in a biologically compatible medium. The method optionally includes a preliminary differential centrifugation step and one or more filtration steps. The invention also provides a method for purifying bacterial minicells in which a sample containing minicells is subjected to a condition that induces parent bacterial cells to adopt a filamentous form, followed by filtration of the sample to separate minicells from parent bacterial cells. The inventive methods optionally include one or more steps to remove endotoxin from purified minicell preparations, and/or treatment of purified minicell preparations with an antibiotic. Additionally, the invention provides purified minicell preparations, prepared according to the foregoing methods, and containing fewer than about 1 contaminating parent bacterial cell per 10 | 07-21-2011 |
20110183021 | Compositions Containing Purine Nucleosides and Manganese and Their Uses - This invention encompasses methods of preserving protein function by contacting a protein with a composition comprising one or more purine nucleosides (such as e.g., adenosine or uridine) and an antioxidant (such as e.g., manganese). In addition, the invention encompasses methods of treating and/or preventing a side effect of radiation exposure and methods of preventing a side effect of radiotherapy comprising administration of a pharmaceutically effective amount of a composition comprising one or more purine nucleosides (such as e.g., adenosine or uridine) and an antioxidant (such as e.g., manganese) to a subject in need thereof. The compositions may comprise | 07-28-2011 |
20110189323 | COSMETIC COMPOSITIONS - There is disclosed a skincare composition suitable for topical application to the skin. The composition comprises two or more active ingredients selected from the group consisting of a) dipalmitoyl hydroxyproline, salts and esters thereof; b) carnitine; and c) an extract of | 08-04-2011 |
20110217402 | Probiotic Derived Non-Viable Material For Allergy Prevention And Treatment - A process for the preparation of a non-viable probiotic composition having anti-allergic (i.e. allergy preventive and/or anti-allergic in a therapeutic sense) properties, the process including the steps of (a) subjecting LGG to cultivation in a suitable culture medium using a batch process; (b) harvesting the culture supernatant at a late exponential phase of the cultivation step; (c) removing liquid contents from the culture supernatant so as to obtain the composition. Also, a composition comprising a proteinaceous mixture, said composition being obtainable by the above process, and the use thereof in a dietetic product preferably for targeting expecting mother's, infants, or children as well as application in food for specific medical purposes. | 09-08-2011 |
20110268828 | CELL RECEPTOR BLOCKER FOR PREVENTING AND TREATING AVIAN INFLUENZA AND OTHER DISEASES CAUSED BY VIRUSES - Use of previously inactivated viral particles of the avian influenza virus or of previously purified antigenic components thereof, alone or in combination with carriers of biological origin in a composition administered via the respiratory system in order to prevent and to treat avian influenza, and also the composition mentioned. The product inhibits the coupling of said pathogenic virus, occupying the cell receptors for viral haemagglutinins. | 11-03-2011 |
20110268829 | QUALITY OF LIFE FOR HEPATITIS C PATIENTS WITH A FORMULATION FOR ADMINISTRATION TO THE ORAL MUCOSA INCLUDING LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS AND N-ACETYL D-GLUCOSAMINE - Disclosed are quick dissolve tablets, each including | 11-03-2011 |
20110280978 | COSMETIC USE OF BOTULINUM TOXIN FOR THE TREATMENT OF EYEBROW AND FOREHEAD PTOSIS, AND UNWANTED EYEBROW EXPRESSION - A method of temporarily elevating the eyebrow position and softening undesirable glabellar muscle activity to affect a more desirable appearance. In a broad aspect the invention comprises injecting small quantities of botulinum toxin (BTX) dissolved in microdroplets of injectable saline carrier to treat the septal and orbital orbicularis oculi muscles, on each side of a patient's face. In sufficient numbers, injected microdroplets of BTX are able to selectively weaken these muscles. This method preferably also includes using microdroplets of BTX to treat: a) the depressor supercilii muscle, on each side; b) the procerus muscle; c) the corrugator supercilii muscle, on each side; and d) the inferior limit of the frontalis muscle where it meets the superior aspect of the orbital portion of the orbicularis oculi muscle. | 11-17-2011 |
20120058211 | DEFINED DOSE THERAPEUTIC PHAGE - The invention provides therapeutic, defined-dose anti-bacterial phage preparations, methods to make such preparations, methods to treat bacterial infections using such preparations and methods to diagnose bacterial infections using such preparations. | 03-08-2012 |
20120100236 | CHROMOBACTERIUM BIOACTIVE COMPOSITIONS AND METABOLITES - Provided are bioactive compounds and metabolites derived from | 04-26-2012 |
20120114776 | METHODS FOR PREPARING PROBIOTIC NANOPARTICLES - Various embodiments of the present invention are directed toward a method for preparing probiotic nanoparticles from natural sources, comprising performing a biological preparation phase such as isolating any cells derived from either prokaryote or eukaryote cells, performing a chemical preparation phase such as performing an enzymatic procedure (or heating, or chemicals) for killing or obtaining cell derived ingredients, performing a physical preparation phase such as performing ultrasonication, and performing a formulation preparation phase such as powderized drying. | 05-10-2012 |
20120121744 | PHARMACEUTICAL COMPOSITION FOR INHIBITING INFECTION AND REPLICATION OF INFLUENZA A AND B VIRUS, AND THE MANUFACTURE THEREOF - Disclosed is a pharmaceutical composition for inhibiting infection and replication of influenza A and B virus, and the manufacture thereof. The pharmaceutical composition is produced by a manufacture of low-temperature disintegrating cyanobacteria, comprising the steps of: (a) mixing cyanobacteria and non-organic solvent to form a suspension containing cyanobacteria; (b) freezing the suspension with a temperature below 0° C. to form a ice block and the ice block being melted at a low temperature, the whole step being repeated at least twice; (c) separating the cyanobacterial residues and extract solution of the suspension; and (d) collecting the isolated cyanobacterial extract solution; wherein the cyanobacterial extract solution is a solution containing cyanobacterial bioactive substances. The pharmaceutical composition is able to effectively inhibit binding of sialic acid and hemagglutinin of influenza A and/or B virus, so as to inhibit infection and replication of influenza virus. Further, this pharmaceutical composition is able to inhibit infection of influenza virus resistant to neuraminidase inhibitors. | 05-17-2012 |
20120121745 | AGENTS FOR THE CONTROL OF LIMNOPERNA SP. - Compositions and methods for controlling | 05-17-2012 |
20120141619 | NON-PROTEIN STABILIZED CLOSTRIDIAL TOXIN PHARMACEUTICAL COMPOSITIONS - A Clostridial toxin pharmaceutical composition comprising a Clostridial toxin, such as a botulinum toxin, wherein the Clostridial toxin present in the pharmaceutical composition is stabilized by a non-protein excipient such as a polyvinylpyrrolidone, a disaccharides, a trisaccharide, a polysaccharide, an alcohol, a metal, an amino acid, a surfactant and/or a polyethylene glycol. | 06-07-2012 |
20120177762 | INHIBITION OF EXOPROTEINS USING BACTERIA OF THE LACTOBACILLUS GENUS - Use of viable bacteria of the | 07-12-2012 |
20120183636 | ANTI-CANCER COMPOSITION COMPRISING AQUATIC MICROBIAL EXTRACT - There is provided an anti-cancer composition comprising an aquatic microbial extract, and there is more particularly provided an anti-cancer composition comprising a | 07-19-2012 |
20120201916 | Quality of life of hepatitis C patients with a formulation for administration to the oral mucosa including freeze dried lysate of selected Lactobacillus or Bifidobacterium species and N-acetyl D-glucosamine - Disclosed are quick dissolve tablets, each including freeze dried lysate of | 08-09-2012 |
20120231099 | COSMETIC USE OF BIFIDOBACTERIUM SPECIES LYSATE FOR THE TREATMENT OF DRYNESS - Cosmetic use of an effective amount of a lysate of at least one microorganism of the genus | 09-13-2012 |
20120244236 | COMPOSITION HAVING LIPOLYSIS-PROMOTING EFFECT - An object of the present invention is to provide an orally ingestible composition that has a lipolysis-promoting effect and an angiotensin-converting enzyme (ACE) inhibitory effect and has no problems with safety as a food such as side effects or toxicity, and a food or drink and a supplement comprising the composition. As a result of diligent studies on various food materials to provide a composition for foods having a lipolysis-promoting effect and an ACE inhibitory effect, the present inventor has found that a composition prepared by using a salmon milt extract, a beer yeast extract, a young barley leaf extract, and chicken collagen in combination has an excellent lipolysis-promoting effect and an ACE inhibitory activity. A food or drink and a supplement having a lipolysis-promoting effect and an ACE inhibitory effect can be provided by using the composition of the present invention as an active ingredient. | 09-27-2012 |
20120301563 | TRANSGENIC PHOTOSYNTHETIC MICROORGANISMS AND PHOTOBIOREACTOR - Provided herein are methods of producing and processing a feedstock from a photosynthetic microorganism. Also provided are various transgenic photosynthetic microorganism and photobioreactors for use in the methods. | 11-29-2012 |
20130011504 | METHOD FOR TREATMENT OF ESOPHAGEAL SPASM - The present invention relates to methods of treating esophageal spasms using | 01-10-2013 |
20130045291 | Anti-Allergic Composition - It is to provide a composition derived from lactic acid bacteria having an anti-allergic effect (an effect of suppressing allergic symptoms such as hay fever) synergistically, and a food product, pet food, etc. containing the composition. It is to prepare a composition having an anti-allergic action, containing | 02-21-2013 |
20130089633 | AGENT FOR IMPROVING LIPID METABOLISM - This invention provides an effective means or method for improving lipid metabolism, and a means or method for treatment or prevention of diseases or disorders associated with the lipid metabolism disorder. Specifically, this invention relates to an agent for improving the lipid metabolism comprising, as active ingredients, broken cells of a lactic acid bacterium, and to a method for enhancing an effect of a lactic acid bacterium for improving the lipid metabolism comprising a step of breaking the lactic acid bacterium. | 04-11-2013 |
20130142896 | LACTOCOCCUS LACTIS STRAIN WITH HIGH VITAMIN K2 PRODUCTION - The present invention relates to a novel wild-type | 06-06-2013 |
20130164398 | Inhibition of Pathogens by Probiotic Bacteria - Compositions containing a lactic acid-producing bacterial strain, e.g., | 06-27-2013 |
20130164399 | CYTOPROTECTIVE AGENT - An object of the present invention is to find a novel and useful component in a culture supernatant of a lactic acid bacterium and to provide an effective utilization method of the component. The utilization method is a cytoprotective agent containing, as an active ingredient, a low-molecular-weight fraction in a culture supernatant of a lactic acid bacterium belonging to | 06-27-2013 |
20130177663 | Bacteriocins and Novel Bacterial Strains - Novel bacteriocins produced by novel bacterial strains are used for at least reducing the levels of colonization by at least one target bacteria in animals, especially poultry. | 07-11-2013 |
20130196011 | ANTIMICROBIAL BACTERIA STRAINS AND USES THEREOF - The present invention provides novel antimicrobial bacteria strains and uses thereof to prepare novel antimicrobial agents. Also provided are the novel antimicrobial agents. | 08-01-2013 |
20130196013 | CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS - Compositions and methods for controlling molluscs, members of the Gastropoda and Bivalvia classes which includes but is not limited to lactones, lactams, carbamates, amides, and/or carboxylic acid containing compounds as active ingredients and/or compounds derived from | 08-01-2013 |
20130216637 | INDUCTION OF A PHYSIOLOGICAL DISPERSION RESPONSE IN BACTERIAL CELLS IN A BIOFILM - The present invention is directed to a compound which induces a physiological dispersion response in bacterial cells in a biofilm. The present invention is also directed to compositions containing this compound, methods of isolating the compound, and uses thereof. | 08-22-2013 |
20130230611 | EXTRUDED NON-REPLICATING PROBIOTIC MICRO-ORGANISMS AND THEIR HEALTH BENEFITS - The present invention generally relates to the field of probiotic micro-organisms, in particular to the field of non-replicating probiotic micro-organisms. Embodiments of the present invention relate to compositions comprising probiotic micro-organisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system. | 09-05-2013 |
20130236581 | FROZEN CONFECTIONS CONTAINING PROBIOTIC MICRO-ORGANISMS - The present invention relates to the field of frozen yoghurt. In particular, the present invention provides frozen yoghurt compositions comprising non-replicating probiotic micro-organisms. These non-replicating probiotic micro-organisms may bioactive heat treated probiotic micro-organisms, for example. The present inventions also relates to health benefits provided by these non-replicating probiotic micro-organisms. | 09-12-2013 |
20130251829 | PROBIOTIC DERIVED NON-VIABLE MATERIAL FOR INFECTION PREVENTION AND TREATMENT - A composition comprising a culture supernatant from a late-exponential growth phase of a batch-cultivation process for a probiotic such as LGG, for use in the treatment or prevention of infection by a pathogen such as | 09-26-2013 |
20130251830 | THERAPEUTIC TREATMENTS USING BOTULINUM NEUROTOXIN - Methods for treating a coronary risk factor (such as hypertension, diabetes, hyperlipidemia and obesity) and/or a respiratory disorder (such as asthma, chronic obstructive pulmonary disease and bronchitis) and/or arthritis by local administration of a botulinum neurotoxin to at least one of a head, neck or shoulder location (for example, by subdermal, subcutaneous or intramuscular administration of the botulinum neurotoxin) of a patient with a coronary risk factor, respiratory disorder or arthritis. | 09-26-2013 |
20130273186 | GAMMA-POLYGLUTAMIC ACID-BASED OCULAR IRRIGATING SOLUTIONS - Ophthalmic irrigating solutions are disclosed. The ophthalmic irrigating solution comprises: a) γ-polyglutamic acid (γ-PGA) and/or salt thereof in an amount effective to increase the viscosity of the irrigating solution, and b) an ophthalmically acceptable aqueous vehicle for the γ-PGA and/or salt thereof. Also disclosed is a method of irrigating ocular tissues of a patient, in which the method comprises introducing to the ocular tissues of the patient an ophthalmic irrigating solution comprising γ-PGA) and/or salt thereof in an amount sufficient to irrigate the ocular tissues of the patient. | 10-17-2013 |
20130273187 | METHOD OF TREATING ACNE - The invention relates to methods of treating acne, which methods comprise topical administering to a skin of a subject in need thereof an effective amount of a lysate of | 10-17-2013 |
20130287874 | SPOONABLE YOGURT PREPARATIONS CONTAINING NON-REPLICATING PROBIOTIC MICRO-ORGANISMS - The present invention relates to the field of spoonable yogurt compositions. In particular, the present invention provides spoonable yogurt compositions comprising non-replicating probiotic micro-organisms. These non-replicating probiotic micro-organisms may be bioactive heat treated probiotic micro-organisms, for example. The present invention also relates to health benefits provided by these non-replicating probiotic micro-organisms. | 10-31-2013 |
20130302454 | Method for preparing fermentation broth of fruits and vegetables - A method for preparing fermentation broth of fruits and vegetables includes steps of mixing fruits, vegetables, bacteria liquid of | 11-14-2013 |
20130316032 | SUBSTANCE FOR PREVENTING AND IMPROVING ARTHRITIS - This application provides a substance containing disrupted cells of an anti-inflammatory lactic acid bacterium and having an effect of preventing or improving arthritis in a subject, a composition containing the substance and the preparation method thereof, and a method for enhancing the effect of preventing and improving arthritis with the use of the substance. | 11-28-2013 |
20130316033 | NOVEL BACTERIUM AND EXTRACTS OF SAID BACTERIUM AND THE USE OF SAME IN DERMATOLOGY - The present invention relates to a novel bacterial strain isolated from groundwater. The invention also relates to bacterial extracts and to the use of same in the context of the treatment of inflammations. More particularly, the present invention relates to novel compositions of interest in the treatment and the prevention of inflammatory disorders, notably dermatological pathologies. | 11-28-2013 |
20140030369 | Soil Amendment Compositions and Methods for Using the Same - Soil amendment compositions and methods for using the same are provided. The subject compositions are aqueous compositions consisting essentially of a carbon-skeleton energy component, a predisposing agent and a vitamin-cofactor component. The subject compositions find use in a variety of soil amendment applications, including: the control of soil born pests and pathogens; the improvement in soil fertility and/or characteristics, e.g. mineral release, water filtration; the neutralization and/or degradation of toxins, etc. | 01-30-2014 |
20140106016 | NOVEL USEFUL ACTIVE AGENT FOR PREVENTING AND/OR TREATING DANDRUFF CONDITIONS OF THE SCALP - The present invention relates to the cosmetic use of a lysate of a bacterium or bacteria belonging to the | 04-17-2014 |
20140113015 | NOVEL STRAIN OF MICROALGA THAT PRODUCES SQUALENE - The invention relates to a novel strain of | 04-24-2014 |
20140120191 | METHOD OF TREATING A DISORDER ASSOCIATED WITH SEQUESTERED BACTERIA - Disclosed herein are methods and compositions for treating a disorder associated with sequestered bacteria in a mammalian subject comprising the step of administering to the subject a combination therapy comprising streptolysin O and antibiotic therapy in an amount effective to treat the disorder. | 05-01-2014 |
20140127336 | Process for the Preparation of a Pharmaceutically Effective Extract from Arthrospira Spec. - A process for the preparation of a pharmaceutically effective extract from the cyanobacterium | 05-08-2014 |
20140178512 | IN SITU FORMATION OF A FILLER - The present invention pertains to a method for the in situ preparation of a filler, comprising the step of applying a polyanionic biopolymer solution at an application site below the dermis of a patient for restoring volume at said application site, wherein the polyanionic biopolymer is selected from pectin and gellan. Furthermore, the present invention pertains to a kit comprising (i) a polyanionic biopolymer solution; and (ii) a solution comprising at least one divalent cation. | 06-26-2014 |
20140186475 | STRAIN OF COBETIA MARINA AND BIOSURFACTANT EXTRACT OBTAINED FROM SAME - The invention discloses a bacterial strain of non pathogenic | 07-03-2014 |
20140205693 | BACTERIAL EXTRACT FOR RESPIRATORY DISORDERS AND PROCESS FOR ITS PREPARATION - The present invention relates to an extract from bacterial strains, such as | 07-24-2014 |
20140295012 | LATENT HUMAN IMMUNODEFICIENCY VIRUS REACTIVATION - Provided herein are methods or reactivating a latent Human Immunodeficiency Virus (HIV) infection in a cell. The methods comprise modulating a level of NF-fB activity in the cell by contacting the cell with an agent that produces a transient first increase in the level of NF-fB activity without a second delayed increase in NF-fB activity. Optionally, a second agent is used to prime the reactivation. Also provided herein is an isolated | 10-02-2014 |
20140314890 | COMBINATION ANTI-CANCER THERAPY - Discloses herein is a combination therapy for treating cancer by administration of a phycocyanin and a chemotherapeutic. | 10-23-2014 |
20140322372 | Bacterial Ribonucleic Acid Cell Wall Compositions and Methods of Making and Using Them - The present invention relates to novel bacterial and mycobacterial compositions containing RNA and cell walls, and methods for making and using these compositions. These compositions have immune stimulating and anti-cancer activity. | 10-30-2014 |
20150044317 | Topical Compositions for Reducing Visible Signs of Aging and Methods of Use Thereof - The present invention relates to the use of lactic acid producing bacteria and the extracellular product thereof in topical compositions. | 02-12-2015 |
20150072033 | EXTRUDED NON-REPLICATING PROBIOTIC MICRO-ORGANISMS AND THEIR HEALTH BENEFITS - The present invention generally relates to the field of pro biotic micro-organisms, in particular to the field of non-replicating probiotic micro-organisms. Embodiments of the present invention relate to compositions comprising probiotic microorganisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system. | 03-12-2015 |
20150079209 | DIABETES-INDUCIBLE BACTERIUM - The present invention provides a diabetes-inducing bacterium and use thereof, and a reagent and a detection method for detecting the bacterium. According to the present invention, enteric colonization of the diabetes-inducing bacterium can be prevented, and diabetes can be treated and/or prevented. | 03-19-2015 |
20150093462 | Watery Lotion Skin Care Compositions And Methods - A watery lotion composition for topical application to skin comprising at least one extract from the fermentation of the microorganism | 04-02-2015 |
20150093463 | NUTRITIONAL COMPOSITION CONTAINING A PEPTIDE COMPONENT WITH ANTI-INFLAMMATORY PROPERTIES AND USES THEREOF - The present disclosure relates to nutritional compositions comprising a protein equivalent source, wherein 20% to 80% of the protein equivalent source includes a peptide component comprising SEQ ID NO 4, SEQ ID NO 13, SEQ ID NO 17, SEQ ID NO 21, SEQ ID NO 24, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO 32, SEQ ID NO 51, SEQ ID NO 57, SEQ ID NO 60, and SEQ ID NO 63, and 20% to 80% of the protein equivalent source comprises an intact protein, a partially hydrolyzed protein, or combinations thereof. The disclosure further relates to methods of reducing the inflammatory response and/or production of proinflammatory cytokines, i.e. Interleukin-17, by providing said nutritional compositions to a target subject. | 04-02-2015 |
20150353611 | IMPROVED NISIN PRODUCTION PROCESS - The present invention relates to fermentation processes. The objective of the invention was to provide methods for producing nisin containing ferments and formulating such ferments into preservatives. It was in particular an object of the present invention to provide improved processes for producing nisin containing ferments by simple and efficient (batch) culturing and allowing for simple down-stream processing either into a liquid, semi-liquid or a dry powder product, having sufficient nisin content and stability, good handling properties and satisfactory organoleptic properties. Such processes are provided, as well as the products that can be obtained with it and their use. | 12-10-2015 |
20160073642 | PRODUCTION PROCESS FOR BIOMASS AND FENGYCIN METABOLITES OF BACILLUS SPECIES AND COMPOSITIONS THEREOF FOR BIOLOGICAL PEST CONTROL - The present invention refers to a process for increasing the production of biomass and metabolites of microorganisms of | 03-17-2016 |
20160145630 | COMPOSITIONS AND METHODS FOR THE IMPROVED PRODUCTION AND DELIVERY OF RNA BY EFFICIENT TRANSCRIPTION TERMINATION - Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis. | 05-26-2016 |
20160174568 | Termite and other wood damaging insect control | 06-23-2016 |
20160199422 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER USING BACTERIA | 07-14-2016 |
20160250141 | USE OF A LYSATE OF A CULTURE OF A BACTERIUM OF THE VITREOSCILLA SP. GENUS FOR PREVENTING AND/OR TREATING HYPERSEBORRHOEIC CONDITIONS OF THE SCALP | 09-01-2016 |
20170232047 | Control of Cellular Redox Levels | 08-17-2017 |
20220132866 | COMPOSITION COMPRISING A MIXTURE OF DNA MOLECULES, USES THEREOF AS BIOLOGICAL INHIBITOR AND METHOD FOR PRODUCTION - The present invention concerns compositions comprising a mixture of DNA molecules suitable for inhibiting a target species, methods and uses employing said compositions and methods for producing the compositions. Said compositions may find utility in amongst others the fields of human and/or veterinary medicine, pest and/or disease control in agriculture or in other fields where inhibition of one or more target species is beneficial. | 05-05-2022 |